Med Sci Monit:原发性开角型青光眼和正常眼压青光眼T辅助细胞模式的比较

2018-04-10 cuiguizhong MedSci原创

上海交通大学医学院第九人民医院眼科的Guo C近日在Med Sci Monit发表了一篇重要的工作,他们原发性开角型青光眼(POAG)患者、正常眼压的青光眼(NPG)患者和正常对照组(NC)中Th细胞百分比和相关的细胞因子水平,发现在POAG、NPG和NC组中观察到不同的Th细胞模式。

上海交通大学医学院第九人民医院眼科的Guo C近日在Med Sci Monit发表了一篇重要的工作,他们原发性开角型青光眼(POAG)患者、正常眼压的青光眼(NPG)患者和正常对照组(NC)中Th细胞百分比和相关的细胞因子水平,发现在POAG、NPG和NC组中观察到不同的Th细胞模式。

HSP60相关的免疫活性在正常眼压的青光眼(NPG)患者中可以发现,但在眼内压(IOP)升高的原发性开角型青光眼(POAG)患者中没有发现。在POAG和NPG患者中都能发现HSP60,但在NPG患者中抗-HSP60的水平更高。这项研究的目的是比较Th细胞百分比和相关的细胞因子水平,来试图解释这种差异。

他们收集POAG、NPG和正常对照(NC)组的血液样品,分离外周血单核细胞并在有或无HSP60刺激下培养。使用流式细胞术和酶联免疫吸附试验来评估培养前后Th1、Th2、Th17和Treg细胞的百分比,以及HSP60抗体水平和相关的细胞因子的水平。

结果他们发现,仅在NPG患者中观察到更高滴度的抗HSP60,具有显着性差异。在POAG和NPG患者中,比较的Th1和Th2细胞百分比以及IL-4水平和IFN-γ水平发现,仅在POAG患者中存在更高比例的Treg细胞。在使用HSP60培养后,观察到POAG、NPG和NC组中Th2所占比例增加,Th1所占比例降低,而Treg所占比例仅在POAG和NC组中增加。

因此,他们总结说,在POAG、NPG和NC组中观察到不同的Th细胞模式。在一些NPG患者中,缺乏Treg细胞,Th细胞的促炎和抗炎反应平衡被打破等可能是上述差异的原因。

原文出处:

Guo, C., et al., Comparison of T Helper Cell Patterns in Primary Open-Angle Glaucoma and Normal-Pressure Glaucoma. Med Sci Monit, 2018. 24: p. 1988-1996.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
    2018-04-12 swallow
  8. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1662201, encodeId=1c3a166220140, content=<a href='/topic/show?id=8a47632105f' target=_blank style='color:#2F92EE;'>#正常眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63210, encryptionId=8a47632105f, topicName=正常眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 10 21:08:00 CST 2018, time=2018-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846660, encodeId=8718184666046, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Sat Feb 02 18:08:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037466, encodeId=1291203e466af, content=<a href='/topic/show?id=8c2493e077d' target=_blank style='color:#2F92EE;'>#辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93707, encryptionId=8c2493e077d, topicName=辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Wed Oct 03 06:08:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796514, encodeId=c2f51e9651420, content=<a href='/topic/show?id=2ef2180454a' target=_blank style='color:#2F92EE;'>#T辅助细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18045, encryptionId=2ef2180454a, topicName=T辅助细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Wed Sep 12 17:08:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046546, encodeId=880f204654690, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon May 07 21:08:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687927, encodeId=4b83168e9276a, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue May 01 00:08:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293996, encodeId=0767129399626, content=<a href='/topic/show?id=6c20e273679' target=_blank style='color:#2F92EE;'>#眼压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72736, encryptionId=6c20e273679, topicName=眼压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608731, encodeId=3b711608e31c3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630783, encodeId=d97d1630e8378, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Apr 12 13:08:00 CST 2018, time=2018-04-12, status=1, ipAttribution=)]

相关资讯

Int Ophthalmol:从以BAK为保护剂的拉坦前列素转换到无防腐剂的拉坦前列素进行治疗时可减少POAG患者的前房闪光!

比利时根特AZ St-Lucas医院眼科的Kestelyn PA 近日在Int Ophthalmol杂志上发表了他们近期的一项工作,他们为了验证BAK诱发前房低度炎症这一假设,设计了一项实验,在原发性开角型青光眼(POAG)患者中,将以BAK作为保护剂的拉坦前列素换成没有防腐剂的拉坦前列素是否会降低眩光水平。

我国原发性开角型青光眼眼颅压力梯度专家共识和建议(2017年)

在2016年中华医学会第11届全国青光眼学术大会期间召开的青光眼学组会议上,针对眼颅压力梯度国际专家共识和建议,在我国青光眼学组委员中进行了宣讲和问卷调查。最终形成《我国原发性开角型青光眼眼颅压力梯度专家共识和建议(2017年)》。

J Ocul Pharmacol Ther:原发性开角型青光眼患者的姿势对眼压和系统血液动力学参数的影响!

希腊Ioannina约阿尼纳大学眼科系的Katsanos A近日在J Ocul Pharmacol Ther.发表了他们一项重要的工作,他们对治疗(tPOAG)和未治疗(uPOAG)的原发性开角型青光眼患者和健康人中,在坐立、仰卧和20°低头(Trendelenburg)等体位的情况下,研究了眼内压(IOP)、收缩压、舒张压和平均动脉血压(SBP,DBP,MAP)的变化。